Athena L V Hobbs

Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii

Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf et al. · Microbiology Spectrum · 2022 · 54 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection

Katherine M. Shea, Athena L V Hobbs, Theresa Jaso et al. · Antimicrobial Agents and Chemotherapy · 2017 · 47 citations · Full text

Pharmacy, Pharmacotherapy, Respiratory Therapy +17

A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals

Athena L V Hobbs, Mikhail S. Gelfand, Kerry O. Cleveland et al. · Journal of Global Antimicrobial Resistance · 2021 · 37 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas et al. · Microbiology Spectrum · 2023 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Effectiveness of a bundled approach to reduce urinary catheters and infection rates in trauma patients

Paige E. Davies, Mitchell J. Daley, Jonathan Hecht et al. · American Journal of Infection Control · 2018 · 29 citations

Medicine, Surgery, Urology +16